Dr. Lesley C Martin, M.D. Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2571 Park Ave, Concord, CA 94520 Phone: 925-674-2100 Fax: 925-689-5135 |
Dr. Kanwaldeep Kaur Rasila, M.D. Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2571 Park Ave, Concord, CA 94520 Phone: 925-674-2100 |
Dr. Sudhathi Chichili, M.D. Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2571 Park Ave, Concord, CA 94520 Phone: 925-674-2100 |
Dr. Walailuk Chaiyarat, MD Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2571 Park Ave, Concord, CA 94520 Phone: 925-674-2100 |
Beverly F. Mcleod, MD Internal Medicine - Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 2571 Park Avenue, Concord, CA 94520 Phone: 925-674-2110 Fax: 925-689-5135 |
Dr. Elizabeth A Odumakinde, M.D. Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2571 Park Ave, Concord, CA 94520 Phone: 925-674-2100 |
News Archive
New research coauthored by Brigham Young University researchers may lead to a more accurate system for early detection, diagnosis, and treatment of prostate cancer.
Whether it's the man or the woman who suggests using a condom makes no difference to how he or she is viewed. However, how the woman suggests it makes a difference. If she highlights her sexuality by incorporating condoms into the sexual scenario as an erotic and fun activity, other women judge her more harshly than if she simply refuses to have sex without a condom or shares her concerns about sexually transmitted infections.
Several news organization have "fact checks" on the reconciliation procedure and health reform provisions.
Strawberry Hill is an internationally significant gothic revival house in Twickenham, built by Horace Walpole from 1747. It has recently undergone a major structural and decorative restoration to revive its eighteenth century appearance.
The Takeda Oncology Company today reported data from a clinical trial evaluating a VELCADE based combination for patients with relapsed/refractory non-Hodgkin's lymphoma (NHL).
› Verified 1 days ago